tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Corey Davis, 1 are a SELL (2.33%), 35 are a BUY (81.4%), 7 are a HOLD (16.28%).
Analyst Corey Davis works with a stock forecast success ratio of 71.43% fulfilled within 404.71 days on average. Previously, Corey Davis worked at LIFESCI.
Corey Davis’s has documented 68 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ZYNE, Zynerba Pharmaceuticals at 15-Aug-2023.
Analyst best performing recommendations are on CARA (CARA THERAPEUTIC).
The best stock recommendation documented was for CARA (CARA THERAPEUTIC) at 10/13/2016. The price target of $20 was fulfilled within 167 days with a profit of $11.91 (147.22%) receiving and performance score of 8.82.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
1
$0.86 (614.29%)
2
1 years 11 months 16 days ago
4/5 (80%)
$-0.2 (-16.67%)
77
Hold
2
$1.86 (1328.57%)
4
1 years 11 months 16 days ago
7/9 (77.78%)
$0.8 (66.67%)
151
Hold
1
$0.86 (614.29%)
3
1 years 11 months 19 days ago
9/17 (52.94%)
$-0.42 (-29.58%)
77
Buy
11
$10.86 (7757.14%)
11
2 years 1 months 16 days ago
3/6 (50%)
$8.53 (345.34%)
103
Hold
2 years 5 months 20 days ago
1/3 (33.33%)
$10.51 (91.47%)
83
What Year was the first public recommendation made by Corey Davis?
